Cardio Ebt Per Ebit from 2010 to 2025

CDIOW Stock  USD 0.03  0  13.68%   
Cardio Diagnostics Ebt Per Ebit yearly trend continues to be fairly stable with very little volatility. Ebt Per Ebit will likely drop to 0.85 in 2025. During the period from 2010 to 2025, Cardio Diagnostics Ebt Per Ebit regression line of quarterly data had mean square error of  0 and geometric mean of  1.00. View All Fundamentals
 
Ebt Per Ebit  
First Reported
2010-12-31
Previous Quarter
1.04
Current Value
0.85
Quarterly Volatility
0.0579053
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cardio Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardio Diagnostics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 134.8 K or Selling General Administrative of 8.4 M, as well as many indicators such as Price To Sales Ratio of 2 K, Dividend Yield of 0.0 or PTB Ratio of 11.67. Cardio financial statements analysis is a perfect complement when working with Cardio Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Cardio Diagnostics Correlation against competitors.

Latest Cardio Diagnostics' Ebt Per Ebit Growth Pattern

Below is the plot of the Ebt Per Ebit of Cardio Diagnostics Holdings over the last few years. It is Cardio Diagnostics' Ebt Per Ebit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardio Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Ebt Per Ebit10 Years Trend
Very volatile
   Ebt Per Ebit   
       Timeline  

Cardio Ebt Per Ebit Regression Statistics

Arithmetic Mean1.00
Geometric Mean1.00
Coefficient Of Variation5.78
Mean Deviation0.03
Median0.99
Standard Deviation0.06
Sample Variance0
Range0.3066
R-Value0.09
Mean Square Error0
R-Squared0.01
Significance0.74
Slope0
Total Sum of Squares0.05

Cardio Ebt Per Ebit History

2025 0.85
2024 1.04
2023 1.16
2021 1.02

About Cardio Diagnostics Financial Statements

Cardio Diagnostics investors use historical fundamental indicators, such as Cardio Diagnostics' Ebt Per Ebit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cardio Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Ebt Per Ebit 1.04  0.85 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cardio Stock Analysis

When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.